Deena M Leslie Pedrioli (Deena Leslie Pedrioli)

Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Embryonic Stem Cells

Capillary Electrophoresis

Gene Expression

Top Venues

Journal of proteome research

Cancer research

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Meneka Rupasinghe, Cristiana Bersaglieri, Deena M Leslie Pedrioli, Patrick G A Pedrioli, Martina Panatta, Michael O Hottiger, Paolo Cinelli, Raffaella Santoro
PRAMEL7 and CUL2 decrease NuRD stability to establish ground-state pluripotency. EMBO reports (2024)
Meneka Rupasinghe, Cristiana Bersaglieri, Deena M Leslie Pedrioli, Patrick G A Pedrioli, Martina Panatta, Michael O Hottiger, Paolo Cinelli, Raffaella Santoro
PRAMEL7 and CUL2 decrease NuRD stability to establish ground-state pluripotency. EMBO reports 25 (3) (2024)
Meneka Rupasinghe, Cristiana Bersaglieri, Deena M Leslie Pedrioli, Patrick G A Pedrioli, Martina Panatta, Michael O Hottiger, Paolo Cinelli, Raffaella Santoro
PRAMEL7 and CUL2 decrease NuRD stability to establish ground-state pluripotency. EMBO reports 25 (3) (2024)
Meneka Rupasinghe, Cristiana Bersaglieri, Deena M Leslie Pedrioli, Patrick G A Pedrioli, Martina Panatta, Michael O Hottiger, Paolo Cinelli, Raffaella Santoro
PRAMEL7 and CUL2 decrease NuRD stability to establish ground-state pluripotency. EMBO reports 25 (3) (2024)
Meneka Rupasinghe, Cristiana Bersaglieri, Deena M Leslie Pedrioli, Patrick G A Pedrioli, Martina Panatta, Michael O Hottiger, Paolo Cinelli, Raffaella Santoro
PRAMEL7 and CUL2 decrease NuRD stability to establish ground-state pluripotency. EMBO reports (2024)
Lorenza P Ferretti, Flurina Böhi, Deena M Leslie Pedrioli, Phil Fang Cheng, Elena Ferrari, Petra Baumgaertner, Abdiel Alvarado-Diaz, Federica Sella, Alessandra Cereghetti, Patrick Turko, Roni H G Wright, Katrien De Bock, Daniel E Speiser, Roberto Ferrari, Mitchell Paul Levesque, Michael O Hottiger
Combinatorial treatment with PARP and MAPK inhibitors overcomes phenotype switch-driven drug resistance in advanced melanoma. Cancer research (2023)
Lin Liu, Jarrod John Sandow, Deena M Leslie Pedrioli, André L Samson, Natasha Silke, Tobias Kratina, Rebecca L Ambrose, Marcel Doerflinger, Zhaoqing Hu, Emma Morrish, Diep Chau, Andrew J Kueh, Cheree Fitzibbon, Marc Pellegrini, Jaclyn S Pearson, Michael O Hottiger, Andrew Ian Webb, Najoua Lalaoui, John Silke
Tankyrase-mediated ADP-ribosylation is a regulator of TNF-induced death. Science advances 8 (19) (2022)
Stephanie C Lüthi, Anna Howald, Kathrin Nowak, Robert Graage, Giody Bartolomei, Christine Neupert, Xaver Sidler, Deena M Leslie Pedrioli, Michael O Hottiger
Establishment of a Mass-Spectrometry-Based Method for the Identification of the In Vivo Whole Blood and Plasma ADP-Ribosylomes. Journal of proteome research 20 (6) (2021)
Kathrin Nowak, Florian Rosenthal, Tobias Karlberg, Mareike Bütepage, Ann-Gerd Thorsell, Birgit Dreier, Jonas Grossmann, Jens Sobek, Ralph Imhof, Bernhard Lüscher, Herwig Schüler, Andreas Plückthun, Deena M Leslie Pedrioli, Michael O Hottiger
Engineering Af1521 improves ADP-ribose binding and identification of ADP-ribosylated proteins. Nature communications 11 (1) (2020)
Deena M Leslie Pedrioli, Mario Leutert, Vera Bilan, Kathrin Nowak, Kapila Gunasekera, Elena Ferrari, Ralph Imhof, Lars Malmström, Michael O Hottiger
Comprehensive ADP-ribosylome analysis identifies tyrosine as an ADP-ribose acceptor site. EMBO reports 19 (8) (2018)